Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bruce

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 7, 2007
IFN-gamma enhances immune responses to E. coli infection in the chickenVijaya Janardhana, Mark E Ford, Matthew P Bruce, et al.
Transgenic Research|June 29, 2013
A new method for producing transgenic birds via direct in vivo transfection of primordial germ cellsScott G Tyack, Kristie A Jenkins, Terri E O'Neil, et al.
Plos One|April 17, 2015
Developing a prognostic micro-RNA signature for human cervical carcinomaChristine How, Melania Pintilie, Jeff P Bruce, et al.
Oncotarget|March 5, 2015
Identification of a microRNA signature associated with risk of distant metastasis in nasopharyngeal carcinomaJeff P Bruce, Angela B Y Hui, Wei Shi, et al.
Molecular Cancer Research : MCR|September 24, 2021
Mutations in Noncoding <i>Cis</i>-Regulatory Elements Reveal Cancer Driver Cistromes in Luminal Breast CancerSamah El Ghamrasni, Rene Quevedo, James Hawley, et al.
Cell Reports|November 1, 2018
Patient-Derived Xenografts for Prognostication and Personalized Treatment for Head and Neck Squamous Cell CarcinomaChristina Karamboulas, Jeffrey P Bruce, Andrew J Hope, et al.
Cell Reports|August 28, 2025
T cell receptor repertoire in cell-free DNA as a proxy for tumor infiltrates in patients treated with pembrolizumabShirin Soleimani, Xuan Li, Ben X Wang, et al.
NPJ Precision Oncology|June 15, 2026
Longitudinal validation of ENLIGHT, an AI predictor of immunotherapy response and resistance, in pan-cancer cohortsChangsu L Park, Gal Dinstag, Carlos D Holanda Lopes, et al.
Nature Communications|August 5, 2017
Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomasSameer Agnihotri, Suganth Suppiah, Peter D Tonge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2020
EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition ProgressionStephanie Lheureux, Ana Oaknin, Swati Garg, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 7, 2007
IFN-gamma enhances immune responses to E. coli infection in the chickenVijaya Janardhana, Mark E Ford, Matthew P Bruce, et al.
Transgenic Research|June 29, 2013
A new method for producing transgenic birds via direct in vivo transfection of primordial germ cellsScott G Tyack, Kristie A Jenkins, Terri E O'Neil, et al.
Plos One|April 17, 2015
Developing a prognostic micro-RNA signature for human cervical carcinomaChristine How, Melania Pintilie, Jeff P Bruce, et al.
Oncotarget|March 5, 2015
Identification of a microRNA signature associated with risk of distant metastasis in nasopharyngeal carcinomaJeff P Bruce, Angela B Y Hui, Wei Shi, et al.
Molecular Cancer Research : MCR|September 24, 2021
Mutations in Noncoding <i>Cis</i>-Regulatory Elements Reveal Cancer Driver Cistromes in Luminal Breast CancerSamah El Ghamrasni, Rene Quevedo, James Hawley, et al.
Cell Reports|November 1, 2018
Patient-Derived Xenografts for Prognostication and Personalized Treatment for Head and Neck Squamous Cell CarcinomaChristina Karamboulas, Jeffrey P Bruce, Andrew J Hope, et al.
Cell Reports|August 28, 2025
T cell receptor repertoire in cell-free DNA as a proxy for tumor infiltrates in patients treated with pembrolizumabShirin Soleimani, Xuan Li, Ben X Wang, et al.
NPJ Precision Oncology|June 15, 2026
Longitudinal validation of ENLIGHT, an AI predictor of immunotherapy response and resistance, in pan-cancer cohortsChangsu L Park, Gal Dinstag, Carlos D Holanda Lopes, et al.
Nature Communications|August 5, 2017
Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomasSameer Agnihotri, Suganth Suppiah, Peter D Tonge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2020
EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition ProgressionStephanie Lheureux, Ana Oaknin, Swati Garg, et al.
Pageof 13